I. Sakaida et al., Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats, DIG DIS SCI, 44(3), 1999, pp. 560-569
The aim of this study was to investigate whether an iron chelator, deferoxa
mine (DFO) can prevent lipid peroxidation, resulting in reduced liver injur
y as well as reducing preneoplastic lesions induced by a choline-deficient
L-amino acid-defined (CDAA) diet. CDAA diet administration resulted in an i
ncreased serum ALT level (367 +/- 58) after two weeks, but simultaneous DFO
treatment for two weeks reduced this elevation of ALT as well as malondial
dehyde (MDA) production in the liver. Feeding rats a CDAA diet for 12 weeks
led to the development of severe liver fibrosis and preneoplastic lesions
detected as enzyme-altered lesions. DFO treatment prevented the expression
of activated stellate cells, resulting in the reduction of liver fibrosis a
s well as reducing the development of preneoplastic lesions. These results
indicate that iron chelation can reduce the development of preneoplastic le
sions in a CDAA diet model.